| Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer NL Shan, J Wahler, HJ Lee, MJ Bak, SD Gupta, H Maehr, N Suh The Journal of steroid biochemistry and molecular biology 173, 122-129, 2017 | 75 | 2017 |
| Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo SS Shin, BS Jeong, BA Wall, J Li, NL Shan, Y Wen, JS Goydos, S Chen Oncogenesis 7 (11), 86, 2018 | 56 | 2018 |
| Breast cancer stem cells: A review of their characteristics and the agents that affect them NL Shan, Y Shin, G Yang, P Furmanski, N Suh Molecular Carcinogenesis 60 (2), 73-100, 2021 | 36 | 2021 |
| KPT-9274, an inhibitor of PAK4 and NAMPT, leads to downregulation of mTORC2 in triple negative breast cancer cells E Cordover, J Wei, C Patel, NL Shan, J Gionco, D Sargsyan, R Wu, L Cai, ... Chemical research in toxicology 33 (2), 482-491, 2019 | 29 | 2019 |
| Tocopherols inhibit estrogen-induced cancer stemness and OCT4 signaling in breast cancer MJ Bak, P Furmanski, NL Shan, HJ Lee, C Bao, Y Lin, WJ Shih, CS Yang, ... Carcinogenesis 39 (8), 1045-1055, 2018 | 20 | 2018 |
| Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma In Situ by Vitamin D Compounds NL Shan, A Minden, P Furmanski, MJ Bak, L Cai, R Wernyj, D Sargsyan, ... Cancer Prevention Research 13 (8), 673-686, 2020 | 15 | 2020 |
| Molecular differences between younger versus older ER-positive and HER2-negative breast cancers T Qing, T Karn, M Rozenblit, J Foldi, M Marczyk, NL Shan, K Blenman, ... NPJ Breast Cancer 8 (1), 119, 2022 | 4 | 2022 |
| Comprehensive analysis of metabolic isozyme targets in cancer M Marczyk, V Gunasekharan, D Casadevall, T Qing, J Foldi, R Sehgal, ... Cancer research 82 (9), 1698-1711, 2022 | 3 | 2022 |
| Intratumour heterogeneity, from hypothesis to the clinic NL Shan, A Kahn, L Pusztai British Journal of Cancer 128 (3), 459-460, 2023 | 2 | 2023 |
| Abstract P5-17-01: Targeting Acetyl-CoA carboxylase in pre-clinical breast cancer models J Foldi, M Marczyk, V Gunasekharan, T Qing, R Sehgal, NL Shan, ... Cancer Research 82 (4_Supplement), P5-17-01-P5-17-01, 2022 | 1 | 2022 |
| Abstract PO5-14-05: Circulating tumor DNA fraction correlates with residual cancer burden post-neoadjuvant chemotherapy in triple negative breast cancer patients NL Shan, B Gould, K Blenman, J Foldi, P Du, F Zhang, M Walsh, L Pusztai Cancer Research 84 (9_Supplement), PO5-14-05-PO5-14-05, 2024 | | 2024 |
| Abstract PO3-25-08: Artificial Intelligence-based screening of small molecule inhibitors of phosphoenolpyruvate carboxykinase 2 (PCK2), a novel cancer therapeutic target AR Hoyo, NL Shan, HK Lin, GE Campos, M Ahmed, S Umlauf, R Cardone, ... Cancer Research 84 (9_Supplement), PO3-25-08-PO3-25-08, 2024 | | 2024 |
| Abstract PD9-09: Molecular differences between younger versus older estrogen receptor positive/human epidermal growth factor receptor-2 negative breast cancers T Qing, T Karn, M Rozenblit, J Foldi, M Marczyk, NL Shan, K Blenman, ... Cancer Research 83 (5_Supplement), PD9-09-PD9-09, 2023 | | 2023 |
| Understanding the Role of Cancer Stemness in Breast Tumorigenesis NL Shan Rutgers The State University of New Jersey, School of Graduate Studies, 2020 | | 2020 |
| Identification of key drivers of cancer stemness and progression regulated by vitamin D compounds in ductal carcinoma in situ breast cancer NL Shan, MJ Bak, L Cai, R Wernyj, D Sargsyan, D Cheng, A Minden, ... Cancer Research 79 (13_Supplement), 5067-5067, 2019 | | 2019 |
| Targeting cancer stem cells with chemopreventive agents for breast cancer prevention NL Shan, J Yang, MJ Bak, J Wahler, N Suh Cancer Research 78 (13_Supplement), 276-276, 2018 | | 2018 |
| Developing a lung metastasis gene signature using a lung tropism model in melanoma Y Wen, MNL Shan, J Li, J Goydos Cancer Research 75 (15_Supplement), 5172-5172, 2015 | | 2015 |
Lajos PusztaiYale School of MedicineVerified email at yale.edu
